Role of magnesium in post cardiac surgery patients in preventing atrial fibrillatio
Not Applicable
- Conditions
- Health Condition 1: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- CTRI/2022/03/040771
- Lead Sponsor
- Aster Medcity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 4 patients undergoing off-pump Coronary Artery Bypass Grafting surgeries
Exclusion Criteria
1.Abnormal renal function (estimated creatinine clearance lower than 60 ml/min)
2.previous diagnosis of atrial fibrillation/chronic atrial fibrillation/intra-operative onset of atrial fibrillation
3.psychatric illness
4.patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of post operative Atrial fibrillation in patients on continuous magnesium infusion to maintain serum magnesium levels between 1.5 to 2 mmol/LTimepoint: 0-72 hours post surgery
- Secondary Outcome Measures
Name Time Method 1.comparison of magnesium levels in each group <br/ ><br>2.hemodynamic status using vasoactive-inotropic score <br/ ><br>3.No.of patients requiring pharmacotherapy other than magnesium for Post operative atrial fibrillation <br/ ><br>4.No.of patients requiring cardioversion for post operative atrial fibrillation <br/ ><br>5.length of ICU stayTimepoint: 0-72 hours post surgery